Onkologie. 2013:7(3):135-139

The incidence of other neoplasms in patients with leukemia

Edvard Geryk1, Radim Štampach2, Jiří Kozel2, Petr Dítě1, Milan Konečný2
1 Fakultní nemocnice, Brno
2 Geografický ústav Přírodovědecké fakulty, Masarykova univerzita Brno

A total of 30,166 cases of leukemia, based on the Czech Cancer Registry in 1976–2005, there were notificated 3,937 multiple cases associated

with the ocurrence of other neoplasms. Of them there were 2,450 (62.2 %) in males and 1,487 (37.8 %) in females, i.e. 14.7 % cases in males and

11 % in females of total registered leukemia. There were diagnosed 2,064 other neoplasms after 1,715 primary leukemias and 2,642 other

primary neoplasms before 2,222 subsequent leukemias. A total of 14 Czech regions were distributed 35.5 % multiple leukemias in the three

regions (Southern and Northern Moravia, Prague). In the average interval 4.9 years in males and 5.5 years in females followed 35.1 % cancer of

skin and melanoma, 16.9 % digestive, 13 % respiratory and 8.4 % urinary system. The expected low representation of advanced clinical stages

in subsequent cancers was not confirmed: in males 43.8 % cancer of oral cavity, 41.5 % respiratory, 34.2 % digestive, 10.6 % urinary and 15.7 %

genital organs; in females 39.4 % respiratory, 30.6 % urinary, 30 % digestive and 28.2 % genital organs, 25 % breast, 25 % oral cavity. Unfortunatelly

a lot of clinical stages were not registered. Before the subsequent leukemias the most frequent were 43.6 % primary cancers of skin

and melanoma as a sign of malignant status. Up to October 2007 in males survived only 12.4 % of primary and 10.3 % subsequent leukemias,

respective 19.7 % and 14 % in females. How many other neoplasms will be diagnosed among 8,000 surviving with leukemia, estimated in the

Czech Republic in 2015? The analyses of multiple neoplasms should be possible to illuminate the mechanisms of susceptibility to multiple cancers

and provide insights into the long-term medical care and preventive interventions that will benefit the growing population of cancer survivors.

of subsequent cancers.

Keywords: leukemia, other primary neoplasms, age-time-space distribution, synchronous and metachronous occurrence, clinical stages

Published: July 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geryk E, Štampach R, Kozel J, Dítě P, Konečný M. The incidence of other neoplasms in patients with leukemia. Onkologie. 2013;7(3):135-139.
Download citation

References

  1. UZIS: Novotvary ČR 2009. Zdravotnická statistika, Praha: UZIS ČR, 2012: 264, ISBN 978-80-7280-975-2, www.uzis.cz.
  2. Konečný, M, Geryk E, Kubíček P, kol. Prevalence nádorů v České republice, 1989-2005-2015. Brno: PřF MU, 2008: 69, ISBN 978-80-903255-2-4.
  3. Ishibe N, Curtis RE. New malignancies following leukemia. In: Curtis RE, et al. New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute, NIH Publ. No. 05-5302. Bethesda, MD, 2006.
  4. Land CE, Saku T, Hayashi Y, et al. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk. Radiat Res 1996; 146(1): 28-36. Go to original source...
  5. Hawkins MM, Wilson LM, Burton HS, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996; 88(5): 270-278. Go to original source... Go to PubMed...
  6. P Le Vu B, de Vathaire F, Shamsaldin A, et al. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 1998; 77(3): 370-377. Go to original source... Go to PubMed...
  7. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325(19): 1330-1336. Go to original source... Go to PubMed...
  8. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 2001; 93(8): 618-629. Go to original source... Go to PubMed...
  9. Kimball Dalton V, Gelber RD, Li F, et al. Second malignancies in patients treated for childhood acute lymphoblastic leukemia. J Clin Oncol 1998; 16(8): 2848-2853. Go to original source... Go to PubMed...
  10. Bhatia S, Sather HN, Pabustan OB, et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002; 99(12): 4257-4264. Go to original source... Go to PubMed...
  11. Pui CH, Cheng C, Leung W, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003; 349(7): 640-649. Go to original source... Go to PubMed...
  12. Walter AW, Hancock ML, Pui CH, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol 1998; 16(12): 3761-3767. Go to original source... Go to PubMed...
  13. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res 1994; 137(Suppl): S17-S67. Go to original source...
  14. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141(3): 259-277. Go to original source...
  15. de Vathaire F, Hardiman C, Shamsaldin A, et al. Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med 1999; 159(22): 2713-2719. Go to original source... Go to PubMed...
  16. Hisada M, Garber JE, Fung CY, et al. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998; 90(8): 606-611. Go to original source... Go to PubMed...
  17. Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 1998; 90(14): 1039-1071. Go to original source... Go to PubMed...
  18. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991; 325(24): 1682-1687. Go to original source... Go to PubMed...
  19. Leung W, Ribeiro RC, Hudson M, et al. Second malignancy after treatment of childhood acute myeloid leukemia. Leukemia 2001; 15(1): 41-45. Go to original source... Go to PubMed...
  20. Socié G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18(2): 348-357. Go to original source... Go to PubMed...
  21. Mellemgaard A, Geisler CH, Storm HH. Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur J Haematol 1994; 53(4): 218-222. Go to original source... Go to PubMed...
  22. Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options Oncol 2004; 5(3): 215-223. Go to original source... Go to PubMed...
  23. Travis LB, Curtis RE, Hankey BF, et al. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992; 84(8): 1422-1427. Go to original source... Go to PubMed...
  24. Hisada M, Biggar RJ, Greene MH, et al. Solid tumors after chronic lymphocytic leukemia. Blood 2001; 98(6): 1979-1981. Go to original source... Go to PubMed...
  25. Parekh K, Rusch V, Kris M. The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia. Cancer 1999; 86(9): 1720-1723. Go to original source...
  26. Socié G, Curtis RE, Klein J. Late complications, including late relapse. In: Carella AM, et al. Chronic myeloid leukemia: Biology and treatment. London, UK, Martin Dunitz Ltd, part 3. 2001; (25): 401-417.
  27. Geryk E, Dítě P, Kozel J, kol. Nádorové multiplicity u české populace. Čas Lék Čes 2010; 149(4): 178-183.
  28. Voglová J, Mužík J, Faber E, et al. Incidence of second malignancies during treatment of chronic myeloid leukemia with tyrosine kinase inhibitors in the Czech Republic and Slovakia. Neoplasma, 2011; 58(3): 256-262. Go to original source... Go to PubMed...
  29. Tesařová P, Karban J, Pytlík R, a kol. Lymfoproliferativní choroby a solidní nádorová duplicita. Sborník XIV. Jihočeské onkol. dny, 11.10. 2007, Č. Krumlov, 2007: 108-111, ISBN 978-80-254-02331-3.
  30. Geryk E, Dítě P, Trna J, kol. Klinická stadia u nemocných s vícečetnými novotvary. Onkologie, 2010; 4(6): 357-361.
  31. van Leeuwen FE, Travis LB. Second cancers. In DeVita VT Jr, et al. Cancer: Principles and practice of oncology, 7th ed. Philadelphia, Lippincott Williams & Wilkins, 2005: 2575-2602.
  32. Bellizzi KM, Rowland JH, Jeffery D, et al. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 2005; 23(34): 8884-8893. Go to original source... Go to PubMed...
  33. Pinto BM, Trunzo JJ. Health behaviors during and after a cancer diagnosis. Cancer 2005; 104(11 Suppl): 2614-2623. Go to PubMed...
  34. Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 2005; 23(2): 276-292. Go to original source... Go to PubMed...
  35. Travis LB, Rabkin CS, Brown LM, et al. Cancer survivorship -genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 2006; 98(1): 1-11. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.